Table 1.
SCI participant demographics
| Pt | Level | Age, years | Gender | Aetiology | Injury, years | ASIA | Motor score (FDI,/5) | Light touch (12) | Pin-prick (12) | Baclofen dose (mg/d) | Years taking baclofen | Spasm frequency score | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCI (Baclofen) | 1 | C7 | 51 | M | T | 11 | C | 5/5 | 2 | 2 | 60 | 2 | 3 |
| 2 | C6 | 30 | M | T | 6 | A | 5/5 | 1 | 1 | 60 | 6 | 4 | |
| 3 | C7 | 57 | F | T | 13 | D | 3/5 | 2 | 2 | 120 | 13 | 2 | |
| 4 | C5/6 | 39 | M | T | 10 | C | 1/5 | 1 | 1 | 500* | 10 | 3 | |
| 6 | C4 | 59 | M | T | 7 | D | 3/5 | 1 | 2 | 160 | 15 | 4 | |
| 7 | C7 | 51 | M | T | 1 | D | 4/5 | 2 | 2 | 80 | 2.5 | 4 | |
| 8 | C5 | 38 | M | T | 1 | D | 4/5 | 2 | 1 | 120 | 1 | 2 | |
| SCI (No-Baclofen) | 9 | C7 | 41 | F | T | 20 | A | 3/5 | 1 | 1 | — | — | 4 |
| 10 | C4 | 58 | M | T | 3 | D | 5/5 | 2 | 2 | — | — | 2 | |
| 11 | C5 | 50 | M | T | 1 | D | 5/5 | 2 | 2 | — | — | 1 | |
| 12 | C5/6 | 34 | M | T | 4 | D | 4/5 | 2 | 2 | — | — | 2 | |
| 13 | C6 | 59 | M | NT | 17 | D | 5/5 | 2 | 2 | — | — | 1 | |
| 14 | C7 | 45 | M | T | 12 | D | 5/5 | 2 | 2 | — | — | 3 | |
| 15 | C4 | 66 | M | T | 3 | D | 5/5 | 1 | 2 | — | — | 2 | |
| 16 | C4 | 64 | M | NT | 6 | D | 5/5 | 2 | 2 | — | — | 2 | |
*Milliquarts via surgically implanted baclofen pump.
M, Male; F, female; T, traumatic; NT, non traumatic; Light touch and pinprick: 1 = impaired, 2 = intact; Spasm frequency score: 0 = no spasms, 1 = one or fewer spasms per day, 2 = between 1 and 5 spasms per day, 3 = 5 to <10 spasms per day, and 4 = 10 or more spasms per day.